Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF)
Ambarella, Bill Holdings And Box Are Among Top 7 Mid Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Express News | Ardent Health Partners Inc : JP Morgan Raises Target Price to $19 From $18
NYSE New 52-Week Highs And Lows
Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $22
Truist Financial analyst David S Macdonald maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success
Truist Financial Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Loop Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Raises Target Price to $21
Loop Capital analyst Timothy Greaves maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and adjusts the target price from $18 to $21.According to TipRanks data, the analyst has a success
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $22
Truist Financial analyst David S Macdonald maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and sets the target price at $22.According to TipRanks data, the analyst has a success rate
A Quick Look at Today's Ratings for Ardent Health Partners(ARDT.US), With a Forecast Between $21 to $27
On Aug 16, major Wall Street analysts update their ratings for $Ardent Health Partners(ARDT.US)$, with price targets ranging from $21 to $27.Morgan Stanley analyst Craig Hettenbach maintains with a
Ardent Health Partners Is Maintained at Buy by Loop Capital
Truist Adjusts Ardent Health Partners' PT to $22 From $21, Keeps Buy Rating
Buy Rating Affirmed: Ardent Health Partners' Impressive Performance and Growth Potential
Express News | Ardent Health Partners Inc : Mizuho Raises Target Price to $21 From $20
Analysts Are Bullish on These Healthcare Stocks: Biote (BTMD), Ardent Health Partners, Inc. (ARDT)
Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $24 Price Target
Ardent Health Partners Analyst Ratings
Loop Capital Initiates Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $18
Loop Capital analyst Timothy Greaves initiates coverage on $Ardent Health Partners(ARDT.US)$ with a buy rating, and sets the target price at $18.According to TipRanks data, the analyst has a success
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating
Truist Financial analyst David S Macdonald maintains $Ardent Health Partners(ARDT.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 64.7% and a total average
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Encompass Health (EHC) and Ardent Health Partners, Inc. (ARDT)